• Publications
  • Influence
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
TLDR
At a median of 10 years, prostate-cancer-specific mortality was low irrespective of the treatment assigned, with no significant difference among treatments.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
TLDR
Among men with locally advanced or metastatic prostate cancer, ADT plus abiraterone and prednisolone was associated with significantly higher rates of overall and failure‐free survival than ADT alone.
...
...